• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Abbott Sees COVID-19 Testing Demand Droop as Restrictions Ease

cafead

Administrator
Staff member
  • cafead   Jun 08, 2021 at 12:52: PM
via Abbott's outlook for rapid COVID-19 testing has changed significantly as the company has seen a sudden drop in COVID-19 testing demand due to shifting in guidelines related to testing for people who are fully vaccinated.

article source
 

<